Caspase signalling controls microglia activation and neurotoxicity

Nature

Volumn 472, Issue 7343, 2011, Pages 319-324

  Burguillos, Miguel A ^a,b,c   Deierborg, Tomas ^c   Kavanagh, Edel ^a   Persson, Annette ^d   Hajji, Nabil ^a,e   Garcia Quintanilla, Albert ^b   Cano, Josefina ^b   Brundin, Patrik ^c   Englund, Elisabet ^d   Venero, Jose L ^b   Joseph, Bertrand ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF SEVILLE   (Spain)

^c LUND UNIVERSITY   (Sweden)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 7; CASPASE 8; CASPASE INHIBITOR; PROTEIN KINASE C DELTA;

ENZYME ACTIVITY; INHIBITION; NERVOUS SYSTEM DISORDER; NEUROLOGY; PATHOGENICITY; PROTEIN; TOXICITY;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CELL DEATH; ENZYME ACTIVITY; FRONTAL CORTEX; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MESENCEPHALON; MICROGLIA; NERVE CELL; NEUROPROTECTION; NEUROTOXICITY; PARKINSON DISEASE; PRIORITY JOURNAL;

ALZHEIMER DISEASE; ANIMALS; CASPASE 3; CASPASE 7; CASPASE 8; CASPASES; CELL DEATH; CELLS, CULTURED; DOPAMINE; ENZYME ACTIVATION; FRONTAL LOBE; GENE KNOCKDOWN TECHNIQUES; HUMANS; LIPOPOLYSACCHARIDES; MICE; MICROGLIA; NEOSTRIATUM; NEUROTOXICITY SYNDROMES; PARKINSON DISEASE; PROTEIN KINASE C-DELTA; RATS; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; TOLL-LIKE RECEPTOR 4;

EID: 79955485064     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature09788     Document Type: Article

References (47)

1. Hanisch, U.K. & Kettenmann, H. Microglia: activesensorandversatileeffectorcells in the normal and pathologic brain. Nature Neurosci. 10, 1387-1394 (2007). (Pubitemid 350014685)
2. Block, M. L, Zecca, L & Hong, J. S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nature Rev. Neurosci. 8, 57-69 (2007). (Pubitemid 46011999)
3. Chao, C. C, Hu, S., Molitor, T.W., Shaskan, E.G. & Peterson, P.K.Activatedmicroglia mediateneuronalcell injuryviaa nitric oxide mechanism. J. Immunol. 149, 2736-2741 (1992).
4. Castano, A., Herrera, A. J., Cano, J. & Machado, A. Lipopolysaccharide intranigral njection induces inflammatory reaction and damage in nigrostriatal dopaminergic system. J. Neurochem. 70, 1584-1592 (1998). (Pubitemid 28136972)
5. Saijo, K. et al. A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 137, 47-59 (2009).
6. Zhao, J. et al. IRF-8/interferon (IFN) consensussequence-binding protein is involved in Toll-like receptor(TLR) signalingand contributes to thecross-talk between TLR and IFN-gamma signaling pathways. J. Biol. Chem. 281, 10073-10080 (2006). (Pubitemid 43864542)
7. Car, B. D. et al. Interferongamma receptordeficientmiceareresistanttoendotoxic shock. J. Exp. Med. 179, 1437-1444 (1994).
8. Jin, J.J., Kim, H. D., Maxwell, J.A., Li, L & Fukuchi, K.Toll-likereceptor4-dependent upregulation ofcytokines in a transgenic mouse modelof Alzheimer's disease. J. Neuroinflammation 5, 23 (2008).
9. Balistreri, C. R. et al. Association between the polymorphismsof TLR4and CD14 genes and Alzheimer's disease. Curr. Pharm. Des. 14, 2672-2677 (2008).
10. Walter, S. et al. Roleofthetoll-like receptor4in neuroinflammation in Alzheimer's disease. Cell. Physiol. Biochem. 20, 947-956 (2007). (Pubitemid 350059737)
11. Nicholson, D. W. et al. Identification and inhibition ofthe ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376, 37-43 (1995).
12. Cohen, G. M. Caspases: the executioners of apoptosis. Biochem. J. 326, 1-16 (1997). (Pubitemid 27386911)
13. Keller, M., Ruegg, A., Werner, S. & Beer, H. D. Activecaspase-1 is a regulatorof unconventional protein secretion. Cell 132, 818-831 (2008). (Pubitemid 351312798)
14. Schulz, J. B. et al. Extendedtherapeuticwindowforcaspaseinhibitionandsynergy with MK-801 in the treatment of cerebral histotoxic hypoxia. Cell Death Differ. 5, 847-857 (1998). (Pubitemid 28484395)
15. Braun, J. S. et al. Neuroprotection bya caspase inhibitor in acute bacterial meningitis. Nature Med. 5, 298-302 (1999). (Pubitemid 29124365)
16. Cutillas, B., Espejo, M., Gil, J., Ferrer, I. & Ambrosio, S. Caspase inhibition protects nigralneuronsagainst6-OHDA-inducedretrogradedegeneration. Neuroreport10, 2605-2608 (1999).
17. Depino, A. M. et al. Microglial activation with atypical proinflammatorycytokine expression in a rat modelof Parkinson'sdisease. Eur.J.Neurosci. 18, 2731-2742 (2003). (Pubitemid 37542126)
18. Kawai, T. & Akira, S.Signalingto NF-κB byToll-likereceptors. Trends Mol.Med. 13, 460-469 (2007).
19. Gibbons, H. M. & Dragunow, M. Microglia induceneuralcelldeath viaa proximity-dependent mechanism involving nitric oxide. Brain Res. 1084, 1-15 (2006).
20. Schumann, R. R. et al. Lipopolysaccharide activates caspase-1 (interleukin-1-convertingenzyme) incultured monocyticandendothelialcells. Blood91, 577-584(1998). (Pubitemid 28053381)
21. Li, P. et al. Micedeficientin IL-1β-converting enzymeared efectivein production of mature IL-1β and resistanttoendotoxicshock. Cell80, 401-411 (1995).
22. Friedlander, R. M. et al. Expression of adominant negative mutant of in terleukin-1β convertingenzyme in transgenic mice prevents neuronal celldeath induced by trophicfactorwithdrawal and ischemic brain injury. J. Exp. Med. 185, 933-940 (1997). (Pubitemid 27119877)
23. Fernandes-Alnemri, T. et al. Invitroactivation of CPP32 and Mch3 by Mch4, a novel humana poptoticcyste ineprotease containing two FADD-likedomains.Proc. Natl Acad. Sci. USA 93, 7464-7469 (1996). (Pubitemid 26277057)
24. Nunez, G., Benedict, M. A., Hu, Y. & Inohara, N. Caspases: the proteases ofthe apoptotic pathway. Oncogene 17, 3237-3245 (1998). (Pubitemid 29043976)
25. Slee, E.A., Adrain, C. & Martin, S.J.Serial killers: orderingcaspaseactivationevents in apoptosis. Cell Death Differ. 6, 1067-1074 (1999).
26. Aliprantis, A. O., Yang, R. B., Weiss, D.S., Godowski, P. & Zychlinsky, A. Theapoptotic signaling pathwayactivated byToll-like receptor-2. EMBOJ. 19, 3325-3336 (2000). (Pubitemid 30428210)
27. Jung, D. Y. et al. TLR4, but notTLR2, signalsautoregulatoryapoptosisofcultured microglia: a critical role of IFN-beta as a decision maker. J. Immunol. 174, 6467-6476 (2005). (Pubitemid 40663842)
28. Kuno, R. et al. Autocrineactivation of microglia bytumornecrosisfactor- alpha.J. Neuroimmunol. 162, 89-96 (2005).
29. Storz, P., Doppler, H. & Toker, A. Protein kinaseCdeltaselectivelyregulatesprotein kinaseD-dependent activation of NF-κB in oxidativestresssignaling. Mol. Cell.Biol. 24, 2614-2626 (2004).
30. Vancurova, I., Miskolci, V. & Davidson, D. NF-κBactivation in tumor necrosisfactor a-stimulated neutrophils is mediated by protein kinase Cδ. Correlation to nuclear IκBa. J. Biol. Chem. 276, 19746-19752 (2001).
31. Reyland, M. E., Anderson, S. M., Matassa, A.A., Barzen, K.A. & Quissell, D.O. Protein kinase Cδ isessential foretoposide-induced apoptosis in salivarygland acinar cells. J. Biol. Chem. 274, 19115-19123 (1999).
32. Czlonkowska, A., Kohutnicka, M., Kurkowska-Jastrzebska, I. & Czlonkowski, A. Microglial reaction in MPTP(1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine) nduced Parkinson's disease mice model. Neurodegeneration 5, 137-143 (1996). (Pubitemid 26248603)
33. Aarli, J. A. Role of cytokines in neurological disorders. Curr. Med. Chem. 10, 1931-1937 (2003). (Pubitemid 37139055)
34. Gonzalez-Scarano, F. & Baltuch, G. Microglia as mediators of inflammatoryand degenerative diseases. Annu. Rev. Neurosci. 22, 219-240 (1999). (Pubitemid 29144887)
35. Jordan, J., Segura, T, Brea, D., Galindo, M. F. & Castillo, J. Inflammation as therapeutic objective in stroke. Curr. Pharm. Des. 14, 3549-3564 (2008).
36. Lenzlinger, P. M., Morganti-Kossmann, M. C, Laurer, H. L & McIntosh, T. K. The dualityoftheinflammatory responsetotraumaticbrain injury.Mol. Neurobiol.24, 169-181 (2001).
37. Allan, S. M. & Rothwell, N. J. Inflammation in central nervous system injury. Phil. Trans. R. Soc. Lond. B 358, 1669-1677 (2003). (Pubitemid 37298635)
38. Karatas, H. et al. A nanomedicine transportsa peptide caspase-3 inhibitoracross the blood-brain barrierand provides neuroprotection. J. Neurosci. 29, 13761-13769 (2009).
39. Bilsland, J. & Harper, S. Caspasesand neuroprotection. Curr. Opin.Investig Drugs3, 1745-1752 (2002).
40. Friedlander, R. M.Apoptosisandcaspases in neurodegenerativediseases. N. Engl. J. Med. 348, 1365-1375 (2003).
41. Le, D. A. et al. Caspaseactivationand neuroprotection incaspase-3-deficientmice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation. Proc. Natl Acad. Sci. USA 99, 15188-15193 (2002). (Pubitemid 35334631)
42. Joseph, B. et al. p57(Kip2)cooperates with Nurr1 in developingdopaminecells. Proc. Natl Acad. Sci. USA 100, 15619-15624 (2003).
43. Bocchini, V. et al. An immortalized cell line expresses properties of activated microglial cells. J. Neurosci. Res. 31, 616-621 (1992).
44. Giulian, D. & Baker, T. J. Characterization of ameboid microglia isolatedfrom developing mammalian brain. J. Neurosci. 6, 2163-2178(1986). (Pubitemid 16043659)
45. Li, J. Y. et al. Lewy bodies in grafted neurons in subjectswith Parkinson'sdisease suggest host-to-graft disease propagation. Nature Med. 14, 501-503 (2008).
46. Joseph, B. et al. Mitochondrial dysfunction is an essential stepfor killing of non-small cell lungcarcinomas resistanttoconventional treatment. Oncogene21, 65-77 (2002). (Pubitemid 34076379)
47. Rite, I., Machado, A., Cano, J. & Venero, J. L Blood-brain barrierdisruption induces in vivo degeneration of nigral dopaminergic neurons. J. Neurochem. 101, 1567-1582 (2007). (Pubitemid 46848862)